Trial Outcomes & Findings for An Institutional Pilot Study to Investigate Physical Activity Patterns in Boys With Hemophilia (NCT NCT02199717)

NCT ID: NCT02199717

Last Updated: 2016-12-14

Results Overview

To determine if the amount of time spent performing moderate to vigorous physical activity (MVPA) engaged in on a weekly basis differs by the level of disease severity in the pediatric hemophilia population.

Recruitment status

COMPLETED

Target enrollment

66 participants

Primary outcome timeframe

7 days

Results posted on

2016-12-14

Participant Flow

Participant milestones

Participant milestones
Measure
Boys With Hemophilia
Use of accelerometer for 1 week
Overall Study
STARTED
66
Overall Study
COMPLETED
66
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

BMI was grouped by hemophilia severity.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Boys With Hemophilia
n=66 Participants
Age, Customized
<=18 years
66 participants
n=66 Participants
Age, Customized
Between 18 and 65 years
0 participants
n=66 Participants
Age, Customized
>=65 years
0 participants
n=66 Participants
Sex/Gender, Customized
Female
0 Participants
n=66 Participants
Sex/Gender, Customized
Male
66 Participants
n=66 Participants
Region of Enrollment
Canada
66 participants
n=66 Participants
BMI
Severe Hemophilia
20.05 kg/m2
STANDARD_DEVIATION 5.82 • n=42 Participants • BMI was grouped by hemophilia severity.
BMI
Mild/Moderate Hemophilia
21.93 kg/m2
STANDARD_DEVIATION 5.34 • n=24 Participants • BMI was grouped by hemophilia severity.
On demand or Prophylaxis Regimen
Severe Hemophilia · On prophylaxis
42 Participants
n=42 Participants • Grouped by hemophilia severity.
On demand or Prophylaxis Regimen
Severe Hemophilia · On demand
0 Participants
n=42 Participants • Grouped by hemophilia severity.
On demand or Prophylaxis Regimen
Mild/Moderate Hemophilia · On prophylaxis
5 Participants
n=24 Participants • Grouped by hemophilia severity.
On demand or Prophylaxis Regimen
Mild/Moderate Hemophilia · On demand
19 Participants
n=24 Participants • Grouped by hemophilia severity.
Severity of Hemophilia
Severe
42 Participants
n=66 Participants
Severity of Hemophilia
Mild/Moderate
24 Participants
n=66 Participants

PRIMARY outcome

Timeframe: 7 days

Population: All statistical analyses were completed using SAS 9.4 (SAS Institute Inc., Cary, NC, USA). Descriptive statistics such as mean (± SD) and range were calculated and provided for demographic variables, accelerometry variables and questionnaire outcomes. Differences between the two groups were examined in exploratory analyses.

To determine if the amount of time spent performing moderate to vigorous physical activity (MVPA) engaged in on a weekly basis differs by the level of disease severity in the pediatric hemophilia population.

Outcome measures

Outcome measures
Measure
Severe Hemophilia
n=42 Participants
Severe Hemophilia
Mild/Moderate Hemophilia
n=24 Participants
Mild/Moderate Hemophilia
MVPA
48 minutes per day
Standard Deviation 20
55 minutes per day
Standard Deviation 18

PRIMARY outcome

Timeframe: 7 days

Population: All statistical analyses were completed using SAS 9.4 (SAS Institute Inc., Cary, NC, USA). Descriptive statistics such as mean (± SD) and range were calculated and provided for demographic variables, accelerometry variables and questionnaire outcomes. Differences between the two groups were examined in exploratory analyses.

To determine if the amount of time spent in sedentary time on a weekly basis differs by the level of disease severity in the pediatric hemophilia population.

Outcome measures

Outcome measures
Measure
Severe Hemophilia
n=42 Participants
Severe Hemophilia
Mild/Moderate Hemophilia
n=24 Participants
Mild/Moderate Hemophilia
Sedentary Time
633.4 minutes per day
Standard Deviation 121.3
327 minutes per day
Standard Deviation 78.73

Adverse Events

Severe Hemophilia

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Vanessa Bouskill NP

Hospital for Sick Children

Phone: 4168135871

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place